These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 24516863)

  • 1. Self-assembled hybrid nanoparticles for targeted co-delivery of two drugs into cancer cells.
    Huang F; You M; Chen T; Zhu G; Liang H; Tan W
    Chem Commun (Camb); 2014 Mar; 50(23):3103-5. PubMed ID: 24516863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enabling anticancer therapeutics by nanoparticle carriers: the delivery of Paclitaxel.
    Liu Y; Zhang B; Yan B
    Int J Mol Sci; 2011; 12(7):4395-413. PubMed ID: 21845085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, characterization, and evaluation of paclitaxel loaded in six-arm star-shaped poly(lactic-co-glycolic acid).
    Chen Y; Yang Z; Liu C; Wang C; Zhao S; Yang J; Sun H; Zhang Z; Kong D; Song C
    Int J Nanomedicine; 2013; 8():4315-26. PubMed ID: 24235829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual tumor-targeted poly(lactic-
    Chen J; Wu Q; Luo L; Wang Y; Zhong Y; Dai HB; Sun D; Luo ML; Wu W; Wang GX
    Int J Nanomedicine; 2017; 12():5745-5760. PubMed ID: 28848351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyaluronic acid-coated PEI-PLGA nanoparticles mediated co-delivery of doxorubicin and miR-542-3p for triple negative breast cancer therapy.
    Wang S; Zhang J; Wang Y; Chen M
    Nanomedicine; 2016 Feb; 12(2):411-20. PubMed ID: 26711968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Developing combination of artesunate with paclitaxel loaded into poly-d,l-lactic-co-glycolic acid nanoparticle for systemic delivery to exhibit synergic chemotherapeutic response.
    Tran BN; Nguyen HT; Kim JO; Yong CS; Nguyen CN
    Drug Dev Ind Pharm; 2017 Dec; 43(12):1952-1962. PubMed ID: 28724314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PLGA-based nanoparticles as cancer drug delivery systems.
    Sadat Tabatabaei Mirakabad F; Nejati-Koshki K; Akbarzadeh A; Yamchi MR; Milani M; Zarghami N; Zeighamian V; Rahimzadeh A; Alimohammadi S; Hanifehpour Y; Joo SW
    Asian Pac J Cancer Prev; 2014; 15(2):517-35. PubMed ID: 24568455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design of a multifunctional PLGA nanoparticulate drug delivery system: evaluation of its physicochemical properties and anticancer activity to malignant cancer cells.
    Wang Z; Chui WK; Ho PC
    Pharm Res; 2009 May; 26(5):1162-71. PubMed ID: 19191012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bypassing multidrug resistance in human breast cancer cells with lipid/polymer particle assemblies.
    Li B; Xu H; Li Z; Yao M; Xie M; Shen H; Shen S; Wang X; Jin Y
    Int J Nanomedicine; 2012; 7():187-97. PubMed ID: 22275834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and in vitro studies of PLGA-DTX nanoconjugate as potential drug delivery vehicle for oral cancer.
    Gupta P; Singh M; Kumar R; Belz J; Shanker R; Dwivedi PD; Sridhar S; Singh SP
    Int J Nanomedicine; 2018; 13(T-NANO 2014 Abstracts):67-69. PubMed ID: 29593398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel.
    Feng SS; Mei L; Anitha P; Gan CW; Zhou W
    Biomaterials; 2009 Jul; 30(19):3297-306. PubMed ID: 19299012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chitosan-Coated Poly(lactic-co-glycolic acid)-Diiodinated boron-Dipyrromethene Nanoparticles Improve Tumor Selectivity and Stealth Properties in Photodynamic Cancer Therapy.
    Voon SH; Tiew SX; Kue CS; Lee HB; Kiew LV; Misran M; Kamkaew A; Burgess K; Chung LY
    J Biomed Nanotechnol; 2016 Jul; 12(7):1431-52. PubMed ID: 29336539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced cancer therapy with pH-dependent and aptamer functionalized doxorubicin loaded polymeric (poly D, L-lactic-co-glycolic acid) nanoparticles.
    Saravanakumar K; Hu X; Shanmugam S; Chelliah R; Sekar P; Oh DH; Vijayakumar S; Kathiresan K; Wang MH
    Arch Biochem Biophys; 2019 Aug; 671():143-151. PubMed ID: 31283911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Passively Targeted Curcumin-Loaded PEGylated PLGA Nanocapsules for Colon Cancer Therapy In Vivo.
    Klippstein R; Wang JT; El-Gogary RI; Bai J; Mustafa F; Rubio N; Bansal S; Al-Jamal WT; Al-Jamal KT
    Small; 2015 Sep; 11(36):4704-22. PubMed ID: 26140363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous delivery of chemotherapeutic and thermal-optical agents to cancer cells by a polymeric (PLGA) nanocarrier: an in vitro study.
    Tang Y; Lei T; Manchanda R; Nagesetti A; Fernandez-Fernandez A; Srinivasan S; McGoron AJ
    Pharm Res; 2010 Oct; 27(10):2242-53. PubMed ID: 20694526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced delivery of Paclitaxel using electrostatically-conjugated Herceptin-bearing PEI/PLGA nanoparticles against HER-positive breast cancer cells.
    Yu K; Zhao J; Zhang Z; Gao Y; Zhou Y; Teng L; Li Y
    Int J Pharm; 2016 Jan; 497(1-2):78-87. PubMed ID: 26617314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved therapeutic effect of folate-decorated PLGA-PEG nanoparticles for endometrial carcinoma.
    Liang C; Yang Y; Ling Y; Huang Y; Li T; Li X
    Bioorg Med Chem; 2011 Jul; 19(13):4057-66. PubMed ID: 21641806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-molecular-weight protamine-modified PLGA nanoparticles for overcoming drug-resistant breast cancer.
    Wang H; Zhao Y; Wang H; Gong J; He H; Shin MC; Yang VC; Huang Y
    J Control Release; 2014 Oct; 192():47-56. PubMed ID: 25003794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Folate-containing reduction-sensitive lipid-polymer hybrid nanoparticles for targeted delivery of doxorubicin.
    Wu B; Yu P; Cui C; Wu M; Zhang Y; Liu L; Wang CX; Zhuo RX; Huang SW
    Biomater Sci; 2015 Apr; 3(4):655-64. PubMed ID: 26222425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-encapsulation of magnetic Fe3O4 nanoparticles and doxorubicin into biodegradable PLGA nanocarriers for intratumoral drug delivery.
    Jia Y; Yuan M; Yuan H; Huang X; Sui X; Cui X; Tang F; Peng J; Chen J; Lu S; Xu W; Zhang L; Guo Q
    Int J Nanomedicine; 2012; 7():1697-708. PubMed ID: 22619520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.